Epithelial neoplasm
MONDO:0005626A benign or malignant neoplasm that arises from and is composed of epithelial cells. This category include adenomas, papillomas, and carcinomas.
Also known as: epithelial neoplasm, epithelioma
16008 clinical trials for this condition and its sub-types, 22 tagged with Epithelial neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Epithelial neoplasm
-
Carcinoma 224 trials · 14,724 incl. sub-types
49 sub-types
- Adenocarcinoma 184 trials · 5,243 incl. sub-types Sub-types →
- Digestive system carcinoma 25 trials · 4,876 incl. sub-types Sub-types →
- Lung carcinoma 137 trials · 3,320 incl. sub-types Sub-types →
- Breast carcinoma 665 trials · 2,688 incl. sub-types Sub-types →
- Squamous cell carcinoma 177 trials · 1,766 incl. sub-types Sub-types →
- Head and neck carcinoma 73 trials · 1,415 incl. sub-types Sub-types →
- Prostate carcinoma 394 trials · 1,321 incl. sub-types Sub-types →
- Renal carcinoma 85 trials · 764 incl. sub-types Sub-types →
- Neuroendocrine carcinoma 106 trials · 744 incl. sub-types Sub-types →
- Transitional cell carcinoma 249 trials · 721 incl. sub-types Sub-types →
- Urinary bladder carcinoma 392 trials · 669 incl. sub-types Sub-types →
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Uterine carcinoma 3 trials · 611 incl. sub-types Sub-types →
- Invasive carcinoma 4 trials · 604 incl. sub-types Sub-types →
- Peritoneal carcinoma 16 trials · 389 incl. sub-types Sub-types →
- In situ carcinoma 25 trials · 318 incl. sub-types Sub-types →
- Skin carcinoma 34 trials · 281 incl. sub-types Sub-types →
- Thyroid gland carcinoma 41 trials · 237 incl. sub-types Sub-types →
- Fallopian tube carcinoma 126 trials · 182 incl. sub-types Sub-types →
- Secondary carcinoma 1 trial · 169 incl. sub-types Sub-types →
- Bone carcinoma 0 trials · 131 incl. sub-types Sub-types →
- Basal cell carcinoma 111 trials · 120 incl. sub-types Sub-types →
- Laryngeal carcinoma 56 trials · 114 incl. sub-types Sub-types →
- Papillary carcinoma 8 trials · 112 incl. sub-types Sub-types →
- Large cell carcinoma 2 trials · 87 incl. sub-types Sub-types →
- Undifferentiated carcinoma 6 trials · 80 incl. sub-types Sub-types →
- Mucin-producing carcinoma 0 trials · 58 incl. sub-types Sub-types →
- Retroperitoneum carcinoma 0 trials · 52 incl. sub-types Sub-types →
- Vulvar carcinoma 24 trials · 45 incl. sub-types Sub-types →
- Thymic carcinoma 41 trials · 44 incl. sub-types Sub-types →
- Penile carcinoma 9 trials · 35 incl. sub-types Sub-types →
- Sarcomatoid carcinoma 1 trial · 26 incl. sub-types Sub-types →
- Vaginal carcinoma 12 trials · 22 incl. sub-types Sub-types →
- Carcinoma of urethra 2 trials · 21 incl. sub-types Sub-types →
- Ureter carcinoma 1 trial · 19 incl. sub-types Sub-types →
- Choroid plexus carcinoma 11 trials Sub-types →
- Basaloid carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Cribriform carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Combined carcinoid and adenocarcinoma 0 trials · 2 incl. sub-types Sub-types →
- Malignant myoepithelioma 2 trials Sub-types →
- Carcinoma ex pleomorphic adenoma 1 trial Sub-types →
- Scrotal carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Trachea carcinoma 1 trial Sub-types →
- Krebs 2 carcinoma 0 trials
- Comedocarcinoma 0 trials
- Epithelial-myoepithelial carcinoma 0 trials Sub-types →
- Glycogen-rich carcinoma 0 trials Sub-types →
- Lipid-rich carcinoma 0 trials Sub-types →
- Lymph node carcinoma 0 trials
-
Glandular cell neoplasm 6 trials · 5,266 incl. sub-types
10 sub-types
- Adenocarcinoma 184 trials · 5,243 incl. sub-types Sub-types →
- Serous neoplasm 0 trials · 207 incl. sub-types Sub-types →
- Mucinous neoplasm 1 trial · 71 incl. sub-types Sub-types →
- Cystadenoma 0 trials · 11 incl. sub-types Sub-types →
- Oncocytic neoplasm 0 trials · 7 incl. sub-types Sub-types →
- Vaginal glandular neoplasm 0 trials · 7 incl. sub-types Sub-types →
- Vulvar glandular neoplasm 0 trials · 5 incl. sub-types Sub-types →
- Villous adenoma 0 trials · 2 incl. sub-types Sub-types →
- Glandular papilloma 0 trials Sub-types →
- Rete ovarii adenoma 0 trials Sub-types →
-
Squamous cell neoplasm 21 trials · 1,836 incl. sub-types
7 sub-types
- Squamous cell carcinoma 177 trials · 1,766 incl. sub-types Sub-types →
- Squamous cell intraepithelial neoplasia 26 trials · 43 incl. sub-types Sub-types →
- Craniopharyngioma 29 trials Sub-types →
- Vulvar squamous neoplasm 0 trials · 28 incl. sub-types Sub-types →
- Vaginal squamous tumor 0 trials · 8 incl. sub-types Sub-types →
- Ovarian squamous cell neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ocular surface squamous neoplasia 1 trial
-
Transitional cell neoplasm 0 trials · 699 incl. sub-types
2 sub-types
- Urothelial neoplasm 2 trials · 693 incl. sub-types Sub-types →
- Brenner tumor 6 trials Sub-types →
-
Ovarian epithelial tumor 14 trials · 664 incl. sub-types
11 sub-types
- Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types Sub-types →
- Ovarian serous tumor 6 trials · 207 incl. sub-types Sub-types →
- Ovarian clear cell tumor 7 trials · 57 incl. sub-types Sub-types →
- Borderline epithelial tumor of ovary 6 trials · 16 incl. sub-types Sub-types →
- Ovarian mucinous neoplasm 1 trial · 16 incl. sub-types Sub-types →
- Ovarian seromucinous tumor 1 trial · 14 incl. sub-types Sub-types →
- Ovarian Brenner tumor 3 trials · 5 incl. sub-types Sub-types →
- Ovarian papillary tumor 0 trials · 2 incl. sub-types Sub-types →
- Ovarian squamous cell neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Ovarian adenoma benign 0 trials Sub-types →
- Ovarian mucinous adenofibroma 0 trials Sub-types →
-
Epithelial tumor of colon 0 trials · 407 incl. sub-types
4 sub-types
- Colon carcinoma 277 trials · 377 incl. sub-types Sub-types →
- Epithelial tumor of the appendix 0 trials · 42 incl. sub-types Sub-types →
- Colon adenoma 17 trials · 32 incl. sub-types Sub-types →
- Neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor 0 trials · 5 incl. sub-types Sub-types →
-
Epithelial neoplasm of rectum 0 trials · 398 incl. sub-types
3 sub-types
- Rectal carcinoma 54 trials · 392 incl. sub-types Sub-types →
- Rectum adenoma 5 trials · 6 incl. sub-types Sub-types →
- Rectum neuroendocrine neoplasm 3 trials · 6 incl. sub-types Sub-types →
-
Epithelial skin neoplasm 0 trials · 310 incl. sub-types
5 sub-types
- Skin carcinoma 34 trials · 281 incl. sub-types Sub-types →
- Benign epithelial skin neoplasm 0 trials · 29 incl. sub-types Sub-types →
- Keratoacanthoma 1 trial Sub-types →
- Sebaceous adenoma 0 trials
- Sweat gland adenoma 0 trials Sub-types →
-
Adenoma 27 trials · 249 incl. sub-types
31 sub-types
- Digestive system adenoma 0 trials · 127 incl. sub-types Sub-types →
- Pituitary gland adenoma 34 trials · 67 incl. sub-types Sub-types →
- Adrenal cortex adenoma 12 trials · 19 incl. sub-types Sub-types →
- Cystadenoma 0 trials · 11 incl. sub-types Sub-types →
- Follicular thyroid adenoma 1 trial · 7 incl. sub-types Sub-types →
- Parathyroid gland adenoma 6 trials Sub-types →
- Oncocytic adenoma 0 trials · 4 incl. sub-types Sub-types →
- Hepatocellular adenoma 2 trials Sub-types →
- Papillary adenoma 2 trials Sub-types →
- Tubular adenoma 2 trials Sub-types →
- Villous adenoma 0 trials · 2 incl. sub-types Sub-types →
- Adenoma of pancreas 1 trial
- Renal adenoma 0 trials · 1 incl. sub-types Sub-types →
- Tubulovillous adenoma 0 trials · 1 incl. sub-types Sub-types →
- Bartholin gland adenoma 0 trials
- Breast adenoma 0 trials Sub-types →
- Clear cell adenoma 0 trials Sub-types →
- Lipoadenoma 0 trials
- Lung adenoma 0 trials Sub-types →
- Microcystic adenoma 0 trials
- Middle ear adenoma 0 trials
- Minor vestibular glands adenoma 0 trials
- Mixed cell adenoma 0 trials Sub-types →
- Mixed somatotroph-lactotroph pituitary gland adenoma 0 trials
- Ovarian adenoma benign 0 trials Sub-types →
- Prostatic adenoma 0 trials
- Rete testis adenoma 0 trials
- Sebaceous adenoma 0 trials
- Sweat gland adenoma 0 trials Sub-types →
- Vaginal adenoma 0 trials Sub-types →
- Water-clear cell adenoma 0 trials
-
Papillary epithelial neoplasm 0 trials · 131 incl. sub-types
9 sub-types
- Papillary carcinoma 8 trials · 112 incl. sub-types Sub-types →
- Papillary urothelial neoplasm 0 trials · 13 incl. sub-types Sub-types →
- Papillomatosis 0 trials · 9 incl. sub-types Sub-types →
- Papilloma 2 trials · 8 incl. sub-types Sub-types →
- Ovarian papillary tumor 0 trials · 2 incl. sub-types Sub-types →
- Papillary adenoma 2 trials Sub-types →
- Endolymphatic sac tumor 1 trial
- Gallbladder papillary neoplasm 0 trials Sub-types →
- Papillary cystic neoplasm 0 trials Sub-types →
-
Basal cell neoplasm 7 trials · 121 incl. sub-types
2 sub-types
- Basal cell carcinoma 111 trials · 120 incl. sub-types Sub-types →
- Benign basal cell neoplasm 0 trials
-
Benign epithelial neoplasm 0 trials · 106 incl. sub-types
25 sub-types
- Benign epithelial skin neoplasm 0 trials · 29 incl. sub-types Sub-types →
- Craniopharyngioma 29 trials Sub-types →
- Adrenal cortex adenoma 12 trials · 19 incl. sub-types Sub-types →
- Papilloma 2 trials · 8 incl. sub-types Sub-types →
- Follicular thyroid adenoma 1 trial · 7 incl. sub-types Sub-types →
- Parathyroid gland adenoma 6 trials Sub-types →
- Kidney oncocytoma 3 trials Sub-types →
- Ameloblastoma 2 trials Sub-types →
- Hepatocellular adenoma 2 trials Sub-types →
- Warthin tumor 1 trial
- Renal adenoma 0 trials · 1 incl. sub-types Sub-types →
- Bartholin gland adenoma 0 trials
- Bartholin gland adenomyoma 0 trials
- Benign adrenal gland pheochromocytoma 0 trials
- Benign basal cell neoplasm 0 trials
- Benign breast adenomyoepithelioma 0 trials
- Benign mesonephroma 0 trials
- Benign ovarian mucinous tumor 0 trials
- Breast adenoma 0 trials Sub-types →
- Lung adenoma 0 trials Sub-types →
- Middle ear adenoma 0 trials
- Minor vestibular glands adenoma 0 trials
- Mucinous adenofibroma 0 trials Sub-types →
- Ovarian adenoma benign 0 trials Sub-types →
- Prostatic adenoma 0 trials
-
Endometrioid tumor 1 trial · 89 incl. sub-types
1 sub-type
- Ovarian endometrial cancer 4 trials · 88 incl. sub-types Sub-types →
-
Intraepithelial neoplasia 25 trials · 71 incl. sub-types
3 sub-types
- Squamous cell intraepithelial neoplasia 26 trials · 43 incl. sub-types Sub-types →
- Prostate intraepithelial neoplasia 2 trials Sub-types →
- Small intestinal intraepithelial neoplasia 1 trial
-
Thymic epithelial neoplasm 14 trials · 56 incl. sub-types
2 sub-types
- Thymic carcinoma 41 trials · 44 incl. sub-types Sub-types →
- Thymoma 44 trials Sub-types →
-
Epithelial tumor of anal canal 0 trials · 34 incl. sub-types
1 sub-type
- Anal canal carcinoma 4 trials · 34 incl. sub-types Sub-types →
-
Sympathetic paraganglioma 0 trials · 16 incl. sub-types
2 sub-types
- Adrenal gland pheochromocytoma 5 trials · 16 incl. sub-types Sub-types →
- Extra-adrenal sympathetic paraganglioma 0 trials
-
Growth hormone-producing pituitary gland neoplasm 0 trials · 5 incl. sub-types
3 sub-types
-
Myoepithelial tumor 2 trials · 4 incl. sub-types
4 sub-types
- Malignant myoepithelioma 2 trials Sub-types →
- Carcinoma ex pleomorphic adenoma 1 trial Sub-types →
- Breast myoepithelial tumor 0 trials Sub-types →
- Parachordoma 0 trials Sub-types →
-
Cystic, mucinous, and serous neoplasm 1 trial · 3 incl. sub-types
1 sub-type
- Mucoepidermoid carcinoma 2 trials Sub-types →
-
Mesonephric neoplasm 1 trial · 3 incl. sub-types
2 sub-types
- Wolffian duct adenocarcinoma 2 trials
- Benign mesonephroma 0 trials
-
Wolffian adnexal tumor 0 trials
-
2 sub-types
- Pancreatic non-functioning delta cell tumor 0 trials
- Pancreatic somatostatinoma 0 trials
Most studied deeper sub-types
-
Killer virus turned against childhood brain cancer
Disease control Recruiting nowThis early-stage trial tests whether a specially engineered herpes virus (G207) is safe to inject directly into the brain tumors of children whose cancer has returned. Up to 24 children aged 3 to 21 will receive the virus, and some will also get a small dose of radiation to help …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug AVZO-1418 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called AVZO-1418 in people with advanced solid tumors that have spread. The goal is to find a safe dose and see if it shrinks tumors. About 480 adults will take part, receiving the drug alone or with other treatments.
Phase 1/2 • Sponsor: Avenzo Therapeutics, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New pill HLD-0915 takes on tough prostate cancer
Disease control Recruiting nowThis study tests an experimental oral drug called HLD-0915 in men with metastatic prostate cancer that has worsened after other treatments. The trial has two phases: Phase 1 checks safety and the best dose, while Phase 2 looks at how well it controls the cancer. About 190 men wil…
Phase 1/2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for liver cancer patients who have no other options
Disease control Recruiting nowThis study is testing a treatment called BSJ019T in Japanese patients with liver cancer that cannot be removed by surgery and has not responded to standard treatments. The goal is to see if the treatment can control the cancer's growth and how safe it is. About 51 participants wi…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New antibody combo aims to supercharge immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called INBRX-106, alone or combined with the immunotherapy Keytruda, in people with advanced solid tumors (including lung, head and neck, melanoma, and others) that have stopped responding to standard treatments. The main goa…
Phase 1/2 • Sponsor: Inhibrx Biosciences, Inc • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could less be more? trial tests reduced radiation and chemo after surgery for HPV-Linked throat cancer
Disease control Recruiting nowThis trial studies people with HPV-positive oropharynx cancer whose tumors can be surgically removed. After surgery, patients are grouped by risk: low-risk patients get no further treatment, intermediate-risk get a lower dose of radiation, and high-risk get lower-dose radiation p…
Phase 2 • Sponsor: Heath Skinner • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Lab-Grown mini tumors could guide pancreatic cancer treatment
Disease control Recruiting nowThis study explores whether growing miniature versions of a patient's own pancreatic tumor in the lab (called organoids) can help doctors choose the most effective drug for that individual. About 25 adults with advanced, inoperable pancreatic cancer will have their tumor organoid…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Recruiting nowThis study tests a powerful combination of treatments for people with advanced liver cancer that cannot be surgically removed. The approach uses heat-based ablation to destroy the main tumor, followed by targeted therapy (lenvatinib), immunotherapy (tislelizumab), and a procedure…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New radiotracer aims to spot hidden cancers
Diagnosis Recruiting nowThis study tests a new radioactive tracer called [68Ga]Ga-PN-EpC1 for PET/CT scans in 30 people with suspected or confirmed epithelial tumors. The tracer targets a protein called EpCAM found on many cancer cells. Researchers want to see if it can find tumors more accurately than …
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Which cancer care model boosts quality of life? large trial seeks answers
Symptom relief Recruiting nowThis study compares two approaches to supportive cancer care for nearly 3,000 adults with cancer. One group gets information through email or their health record, while the other works one-on-one with a lay health worker over 12 months. The goal is to see which model better impro…
Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC